Skip to main content
. 2024 Mar 6;16(5):1071. doi: 10.3390/cancers16051071

Figure 3.

Figure 3

Survival following treatment with or without immuno-molecular therapy (IMT) added to chemotherapy alone or chemotherapy with or without radiation (CT ± RT) in propensity-score-balanced patients diagnosed between 2013 and 2019 with an embedded adjusted hazard ratio (AHR) and 95% confidence interval (CI) for patients treated with CT ± RT plus IMT compared with CT ± RT (A). Forest plot for all patients with stage IVB cervical cancer diagnosed between 2013 and 2019 and subgroups of these patients showing the reduced AHR (95% CI) following first-line treatment with CT ± RT plus IMT compared with CT ± RT (B).